Abstract
Isoniazid (INH) therapy is associated with a significant incidence of idiosyncratic liver failure. We recently reported eight cases of INH-induced liver failure in which patients had antidrug and anticytochrome P450 antibodies. However, it was unclear what role these antibodies play in the mechanism of INH-induced liver injury. Here, we report that the dominant isotype of anti-INH antibodies was IgG, with IgG3 being the dominant subtype. IgG3 antibodies are associated with a Th1-type immune response and fix complement. IgG3 antibodies have been associated with other forms of liver injury and may play a pathogenic role in INH-induced liver injury.
Original language | English (US) |
---|---|
Pages (from-to) | 738-740 |
Number of pages | 3 |
Journal | Chemical Research in Toxicology |
Volume | 27 |
Issue number | 5 |
DOIs | |
State | Published - May 19 2014 |
ASJC Scopus subject areas
- Toxicology